Business Description
PROCEPT BioRobotics Corp
NAICS : 339112
SIC : 3841
ISIN : US74276L1052
Total Employee Number:
888Description
PROCEPT BioRobotics Corp is a medical device company that develops, manufactures, and sells robotic systems for minimally invasive urologic surgery. Its principal offering is the AquaBeam Robotic System, which uses Aquablation therapy, an image-guided, heat-free waterjet ablation technique, to treat benign prostatic hyperplasia (BPH), a common condition in men. The company also markets the HYDROS Robotic System, a next-generation platform. PROCEPT sells its systems, single-use handpieces, and related consumables primarily to hospitals, ambulatory surgery centers, and urologists. Revenue is generated through system placements and the recurring sale of disposable instruments used in each procedure. The company generates the majority of its revenue in the United States, where it has expanded its installed base and trained physician network, and it also sells in selected international markets. PROCEPT is headquartered in San Jose, California.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.94 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | -0.78 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.85 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 48.6 | |||||
3-Year EBITDA Growth Rate | 4.8 | |||||
3-Year EPS without NRI Growth Rate | 2.9 | |||||
3-Year FCF Growth Rate | 17.5 | |||||
3-Year Book Growth Rate | 13.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 24.14 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 22.04 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.05 | |||||
9-Day RSI | 1.32 | |||||
14-Day RSI | 4.65 | |||||
3-1 Month Momentum % | -25.47 | |||||
6-1 Month Momentum % | -34.32 | |||||
12-1 Month Momentum % | -70.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.55 | |||||
Quick Ratio | 5.35 | |||||
Cash Ratio | 3.55 | |||||
Days Inventory | 217.16 | |||||
Days Sales Outstanding | 98 | |||||
Days Payable | 44.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.9 | |||||
Shareholder Yield % | 0.2 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.22 | |||||
Operating Margin % | -33.86 | |||||
Net Margin % | -32.54 | |||||
EBITDA Margin % | -29.34 | |||||
FCF Margin % | -23.99 | |||||
OCF Margin % | -20.97 | |||||
ROE % | -30.16 | |||||
ROA % | -21.96 | |||||
ROIC % | -53.62 | |||||
3-Year ROIIC % | -18.23 | |||||
ROC (Joel Greenblatt) % | -65.56 | |||||
ROCE % | -24.08 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.4 | |||||
PB Ratio | 3.43 | |||||
Price-to-Tangible-Book | 3.44 | |||||
EV-to-EBIT | -9.1 | |||||
EV-to-EBITDA | -9.76 | |||||
EV-to-Revenue | 2.86 | |||||
EV-to-Forward-Revenue | 1.96 | |||||
EV-to-FCF | -11.97 | |||||
Price-to-GF-Value | 0.24 | |||||
| Price-to-Net-Current-Asset-Value | 4.15 | |||||
| Price-to-Net-Cash | 13.14 | |||||
Earnings Yield (Greenblatt) % | -10.99 | |||||
FCF Yield % | -7.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PROCEPT BioRobotics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 6,054.191 | ||
| EPS (TTM) (MXN) | -34.919 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 61.44 | ||
| 14-Day RSI | 4.65 | ||
| 14-Day ATR (MXN) | 0.093308 | ||
| 20-Day SMA (MXN) | 357 | ||
| 12-1 Month Momentum % | -70.67 | ||
| 52-Week Range (MXN) | 356 - 1217.38 | ||
| Shares Outstanding (Mil) | 57.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PROCEPT BioRobotics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PROCEPT BioRobotics Corp Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-02-26 | In 157 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-25 16:30 | In 157 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-25 | In 156 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-04 16:30 | In 44 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 43 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 16:30 | -- | ||
| Second quarter earnings results for 2026 | 2026-08-04 | -- | ||
| Guidance call for 2026 | 2026-06-16 13:40 | -- | ||
| General meeting for 2026 | 2026-06-09 13:00 | -- | ||
| 46th Annual William Blair Growth Stock Conference | 2026-06-02 13:00 | -- |
Show
Entries
PROCEPT BioRobotics Corp Frequently Asked Questions
What is PROCEPT BioRobotics Corp(MEX:PRCT)'s stock price today?
The current price of MEX:PRCT is MXN357.00. The 52 week high of MEX:PRCT is MXN1217.38 and 52 week low is MXN356.00.
When is next earnings date of PROCEPT BioRobotics Corp(MEX:PRCT)?
The next earnings date of PROCEPT BioRobotics Corp(MEX:PRCT) is 2026-11-04 Est..
Does PROCEPT BioRobotics Corp(MEX:PRCT) pay dividends? If so, how much?
PROCEPT BioRobotics Corp(MEX:PRCT) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers